‹ ›

This content requires a premium subscription.
Please log in or subscribe to continue.
Artwork for MPR Weekly Dose #60 - The FDA stand by remdesivir; Who should get the vaccine first? Xolair and Hetlioz gain expanded approvals; And a novel neuroblastoma treatment
MPR Weekly Dose

MPR Weekly Dose #60 - The FDA stand by remdesivir; Who should get the vaccine first? Xolair and Hetlioz gain expanded approvals; And a novel neuroblastoma treatment
30
00:00:00 / 00:09:40